Review: Potassium channels in the human fetoplacental vasculature

Placenta

Volumn 32, Issue SUPPL. 2, 2011, Pages

  Wareing, M ^a   Greenwood, S L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Placenta; Potassium channel expression; Potassium channel function

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; POTASSIUM CHANNEL; POTASSIUM CHANNEL ATP; POTASSIUM CHANNEL KV2.1; POTASSIUM CHANNEL KV9.3; UNCLASSIFIED DRUG;

CONFERENCE PAPER; FETOPLACENTAL UNIT; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULARIZATION;

ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MUSCLE, SMOOTH, VASCULAR; PLACENTA; POTASSIUM CHANNELS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 79952006625     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.12.022     Document Type: Conference Paper

References (45)

1. Coetzee WA, Amarillo Y, Chiu J, Chow A, Lau D, McCormack T, et al. Molecular diversity of K+ channels. Ann N Y Acad Sci; 1999:233-85.
2. Lawson K, McKay NG. Modulation of potassium channels as a therapeutic approach. Curr Pharm Des; 2006:459-70.
3. Olson TM, Terzic A. Human K(ATP) channelopathies: diseases of metabolic homeostasis. Pflugers Arch; 2010:295-306.
4. V7 channelopathies. Pflugers Arch; 2010:277-88.
5. Jackson WF. Potassium channels in the peripheral microcirculation. Microcirculation; 2005:113-27.
6. Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, et al. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev; 2005:473-508.
7. Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y, et al. International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels. Pharmacol Rev; 2005:509-26.
8. Wei AD, Gutman GA, Aldrich R, Chandy KG, Grissmer S, Wulff H. International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev; 2005:463-72.
9. Goldstein SA, Bayliss DA, Kim D, Lesage F, Plant LD, Rajan S. International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels. Pharmacol Rev; 2005:527-40.
10. Moudgil R, Michelakis ED, Archer SL. The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension. Microcirculation; 2006:615-32.
11. Torres YP, Morera FJ, Carvacho I, Latorre R. A marriage of convenience: beta-subunits and voltage-dependent K+ channels. J Biol Chem; 2007:24485-9. (Pubitemid 47347494)
12. Dora KA. Cell-cell communication in the vessel wall. Vasc Med; 2001:43-50.
13. Edwards G, Feletou M, Weston AH. Endothelium-derived hyperpolarising factors and associated pathways: a synopsis. Pflugers Arch; 2010:863-79.
14. Poston L. The control of blood flow to the placenta. Exp Physiol; 1997:377-87.
15. Xie H, Triggle CR. Acetylcholine relaxes the human umbilical artery by an endothelium-independent but ouabain and tetraethylammonium-sensitive process. Proc West Pharmacol Soc; 1994:31-3.
16. Guiet-Bara A, Bara M. Evidence of K and Ca channels in endothelial cells of human allantochorial placental vessels. Cell Mol Biol (Noisy-le-grand); 2002: OL317-322.
17. Guiet-Bara A, Ibrahim B, Leveteau J, Bara M. Calcium channels, potassium channels and membrane potential of smooth muscle cells of human allantochorial placental vessels. Bioelectrochem Bioenerg; 1999:407-13.
18. Hampl V, Bibova J, Stranak Z, Wu X, Michelakis ED, Hashimoto K, et al. Hypoxic fetoplacental vasoconstriction in humans is mediated by potassium channel inhibition. Am J Physiol Heart Circ Physiol; 2002:H2440-9.
19. Bisseling TM, Versteegen MG, van der Wal S, Copius Peereboom-Stegeman JJ, Borggreven JM, Steegers EA, et al. Impaired KATP channel function in the fetoplacental circulation of patients with type 1 diabetes mellitus. Am J Obstet Gynecol; 2005:973-9. (Pubitemid 40311298)
20. Sand A, Andersson E, Fried G. Nitric oxide donors mediate vasodilation in human placental arteries partly through a direct effect on potassium channels. Placenta; 2006:181-90.
21. Wareing M, Bai X, Seghier F, Turner CM, Greenwood SL, Baker PN, et al. Expression and function of potassium channels in the human placental vasculature. Am J Physiol Regul Integr Comp Physiol; 2006:R437-46.
22. Mills TA, Cowley EJ, Greenwood SL, Sibley CP, Wareing M. 4-Aminopyridine sensitivity in human placental chorionic plate arteries. Proc Physiol Soc; 2009:C23.
23. Moudgil R, Michelakis ED, Archer SL. Hypoxic pulmonary vasoconstriction. J Appl Physiol; 2005:390-403. (Pubitemid 40041273)
24. v1.5 channel expression in human placental resistance arteries of normal pregnancy and fetal growth restriction. Proc Physiol Soc; 2010:C04.
25. v1.5 in human placental arteries? Proc Physiol Soc; 2010:C05.
26. Kiernan MF, Barrie A, Szkolar J, Mills TA, Wareing M. Functional evidence for oxygen-sensitive voltage-gated potassium channels in human placental vasculature. Placenta; 2010:553-5.
27. 2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells. Circ Res; 2004:308-18.
28. Corcoran J, Lacey H, Baker PN, Wareing M. Altered potassium channel expression in the human placental vasculature of pregnancies complicated by fetal growth restriction. Hypertens Pregnancy; 2008:1-12.
29. Fyfe GK, Corcoran J, Panicker S, Garside RA, Baker PN, Jones RL, et al. Expression of an electrically silent voltage-gated potassium channel in the human placenta. Proc Physiol Soc; 2009:PC54.
30. v7-modulating drugs. Curr Opin Pharmacol; 2008:65-74.
31. Yeung SY, Pucovsky V, Moffatt JD, Saldanha L, Schwake M, Ohya S, et al. Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity. Br J Pharmacol; 2007:758-70.
32. V7 channels? Reprod Sci; 2009:163A.
33. Jewsbury S, Baker PN, Wareing M. Relaxation of human placental arteries and veins by ATP-sensitive potassium channel openers. Eur J Clin Invest; 2007:65-72. (Pubitemid 44934774)
34. Dong YL, Vegiraju S, Chauhan M, Gangula PR, Hankins GD, Goodrum L, et al. Involvement of calcitonin gene-related peptide in control of human fetoplacental vascular tone. Am J Physiol Heart Circ Physiol; 2004:H230-9.
35. Howlett AC, Mukhopadhyay S. Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem Phys Lipids; 2000:53-70.
36. Sobey CG. Potassium channel function in vascular disease. Arterioscler Thromb Vasc Biol; 2001:28-38.
37. Satoh S, Koyanagi T, Fukuhara M, Hara K, Nakano H. Changes in vascular resistance in the umbilical and middle cerebral arteries in the human intrauterine growth-retarded fetus, measured with pulsed Doppler ultrasound. Early Hum Dev; 1989:213-20.
38. Wareing M, Greenwood SL, Fyfe GK, Baker PN. Reactivity of human placental chorionic plate vessels from pregnancies complicated by intrauterine growth restriction (IUGR). Biol Reprod; 2006:518-23.
39. Gutterman DD, Miura H, Liu Y. Redox modulation of vascular tone: focus of potassium channel mechanisms of dilation. Arterioscler Thromb Vasc Biol; 2005:671-8.
40. Takagi Y, Nikaido T, Toki T, Kita N, Kanai M, Ashida T, et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch; 2004:49-55.
41. Mills TA, Wareing M, Shennan AH, Poston L, Baker PN, Greenwood SL. Acute and chronic modulation of placental chorionic plate artery reactivity by reactive oxygen species. Free Radic Biol Med; 2009:159-66.
42. Yoneyama Y, Sawa R, Suzuki S, Shin S, Power GG, Araki T. The relationship between uterine artery Doppler velocimetry and umbilical venous adenosine levels in pregnancies complicated by preeclampsia. Am J Obstet Gynecol; 1996:267-71. (Pubitemid 26037722)
43. Luksha L, Luksha N, Kublickas M, Nisell H, Kublickiene K. Diverse mechanisms of endothelium-derived hyperpolarizing factor-mediated dilatation in small myometrial arteries in normal human pregnancy and preeclampsia. Biol Reprod; 2010:728-35.
44. Ernst LM, Parkash V. Placental pathology in fetal bartter syndrome. Pediatr Dev Pathol; 2002:76-9.
45. Enklaar T, Zabel BU, Prawitt D. Beckwith-Wiedemann syndrome: multiple molecular mechanisms. Expert Rev Mol Med; 2006:1-19.